Previous publications suggest gender difference in outcome parameters after pacemaker implantation. Aim of this study is to investigate gender differences in patients with pacemaker. Implanted devices, indication for implantation and pacemaker follow up data of patients will be included. Survival data including cause of death will be documented. Prevalent comorbidities and relevant laboratory data will be recorded.
Full Title of Study: “Morbidity, Mortality and Gender Differences in Patients With Pacemakers; a Large-scale Single-center Cohort Study”
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: March 31, 2016
- Other: No intervention, retrospective analysis only.
- No intervention, retrospective analysis only.
Arms, Groups and Cohorts
- Patients with implanted pacemaker
- Patients with implanted cardiac pacemaker registered in pacemaker database of the Department of Cardiology at the Medical University Vienna were included.
Clinical Trial Outcome Measures
- Survival after pacemaker implantation
- Time Frame: 10 years
- Null hypothesis: There is no survival difference between women and men after pacemaker Implantation.
- Implantation rates of single- or dual-chamber Pacemaker in women/men.
- Time Frame: Data obtained: April 30th, 2015
- Null hypothesis: Women and men have equal implantation rates of single- and dual-chamber pacemakers.
- Survival of women/men after single- or dual-chamber pacemaker implantation.
- Time Frame: 10 years
- Null hypothesis: Survival after single- or dual-chamber pacemaker implantation is equal.
Participating in This Clinical Trial
- All patients registered in the pacemaker database of the Department of Cardiology at the Medical University Vienna. Patients get registered when clinical follow up of an implanted Pacemaker is done. Exclusion Criteria:
- For survival analysis: No valid match of first name AND surname AND date of birth with patients' insurance data. – For analysis of comorbidities: Not a single documented diagnose was found in our electronic clinic-wide patients' information system.
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
- Lead Sponsor
- Medical University of Vienna
- Provider of Information About this Clinical Study
- Principal Investigator: Mariann Gyongyosi, Cardiologist, Assoc. Prof. Univ.-Doz. Dr. – Medical University of Vienna
- Overall Official(s)
- Mariann Gyöngyösi, MD, PhD, Principal Investigator, Medical University of Vienna
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.